AskY Therapeutics, Inc. — Form D
AskY Therapeutics, Inc. of Owings Mills, MD, a company, filed a Form D exempt-offering notice with the SEC on 2024-06-04. The offering totals $1.5M, of which $460K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-06-04
- Form: D
- Accession: 0000950123-24-006105
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $460K
- Remaining: $1.0M
- Minimum investment: $20K
- Investors: 12
- Date of first sale: 2024-05-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-515103
Issuer
- Name: AskY Therapeutics, Inc.
- CIK: 0001962108
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 12405 Hunters Glen, Owings Mills, MD, 21117
- Phone: (713) 715-6820
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Alexander Krupnick | Director | Houston, TX |
| Dan Watkins | Director | Houston, TX |
| John Westwick | Director | Santa Barbara, CA |
| Alexander Krupnick | Executive Officer | Houston, TX |
| Dan Watkins | Executive Officer | Houston, TX |
Other filings by this issuer (1)
More